DABIGATRAN ETEXILATE vs DACOMITINIB: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
DABIGATRAN ETEXILATE vs DACOMITINIB: Safety Overview
| Metric | DABIGATRAN ETEXILATE | DACOMITINIB |
|---|---|---|
| Total FAERS Reports | 37,091 | 682 |
| Deaths Reported | 5,806 | 325 |
| Death Rate | 15.7% | 47.7% |
| Hospitalizations | 21,235 | 168 |
| Average Patient Age | 74.4 yrs | 64.0 yrs |
| % Female Patients | 45.8% | 52.0% |
| FDA Approval Date | Aug 12, 2024 | Sep 27, 2018 |
| Manufacturer | Apotex Corp. | Pfizer Laboratories Div Pfizer Inc |
| Route | ORAL | ORAL |
| Marketing Status | Prescription | Prescription |